Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Louis Paillasseur

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Biomed Research International|April 1, 2014
Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbiditiesPierre-Régis Burgel, Jean-Louis Paillasseur, Nicolas Roche
BMC Pulmonary Medicine|May 20, 2026
Classification and regression trees to identify COPD subgroups in clinical trial populations: insights from the IMPACT trialLucile Regard, Jean-Louis Paillasseur, Pierre-Régis Burgel, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2021
Reply to Kuek <i>et al.</i>: Optimism with Caution: Elexacaftor-Tezacaftor-Ivacaftor in Patients with Advanced Pulmonary DiseasePierre-Régis Burgel, Jennifer Da Silva, Jean-Louis Paillasseur, et al.
BMC Pulmonary Medicine|July 14, 2019
Randomized controlled trials of pharmacological treatments to prevent COPD exacerbations: applicability to real-life patientsLaurie Pahus, Pierre-Régis Burgel, Nicolas Roche, et al.
Springerplus|December 6, 2013
Patient eligibility criteria for a surgical treatment that enhances tissue sealing by use of a medicated sponge: observational study ELITECyril Raiffort, Farid Benabdallah, Jean-Louis Paillasseur, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 29, 2015
Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary diseaseThierry Perez, Pierre Régis Burgel, Jean-Louis Paillasseur, et al.
The European Respiratory Journal|December 23, 2018
Cluster and CART analyses identify large subgroups of adults with cystic fibrosis at low risk of 10-year deathPierre-Régis Burgel, Lydie Lemonnier, Clémence Dehillotte, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|October 12, 2014
Phenotypes influencing low physical activity in maintenance dialysisMarine Panaye, Anne Kolko-Labadens, Catherine Lasseur, et al.
Respiratory Research|June 11, 2014
Tiotropium might improve survival in subjects with COPD at high risk of mortalityPierre-Régis Burgel, Jean-Louis Paillasseur, Daniel Dusser, et al.
Plos One|December 14, 2012
Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortalityPierre-Régis Burgel, Jean-Louis Paillasseur, Bernard Peene, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Biomed Research International|April 1, 2014
Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbiditiesPierre-Régis Burgel, Jean-Louis Paillasseur, Nicolas Roche
BMC Pulmonary Medicine|May 20, 2026
Classification and regression trees to identify COPD subgroups in clinical trial populations: insights from the IMPACT trialLucile Regard, Jean-Louis Paillasseur, Pierre-Régis Burgel, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2021
Reply to Kuek <i>et al.</i>: Optimism with Caution: Elexacaftor-Tezacaftor-Ivacaftor in Patients with Advanced Pulmonary DiseasePierre-Régis Burgel, Jennifer Da Silva, Jean-Louis Paillasseur, et al.
BMC Pulmonary Medicine|July 14, 2019
Randomized controlled trials of pharmacological treatments to prevent COPD exacerbations: applicability to real-life patientsLaurie Pahus, Pierre-Régis Burgel, Nicolas Roche, et al.
Springerplus|December 6, 2013
Patient eligibility criteria for a surgical treatment that enhances tissue sealing by use of a medicated sponge: observational study ELITECyril Raiffort, Farid Benabdallah, Jean-Louis Paillasseur, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 29, 2015
Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary diseaseThierry Perez, Pierre Régis Burgel, Jean-Louis Paillasseur, et al.
The European Respiratory Journal|December 23, 2018
Cluster and CART analyses identify large subgroups of adults with cystic fibrosis at low risk of 10-year deathPierre-Régis Burgel, Lydie Lemonnier, Clémence Dehillotte, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|October 12, 2014
Phenotypes influencing low physical activity in maintenance dialysisMarine Panaye, Anne Kolko-Labadens, Catherine Lasseur, et al.
Respiratory Research|June 11, 2014
Tiotropium might improve survival in subjects with COPD at high risk of mortalityPierre-Régis Burgel, Jean-Louis Paillasseur, Daniel Dusser, et al.
Plos One|December 14, 2012
Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortalityPierre-Régis Burgel, Jean-Louis Paillasseur, Bernard Peene, et al.
Pageof 3